Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID4286 | AMGIMNSFVNDIFERI | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5070 | FVNDIFERI | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5164 | GIMNSFVNDIFERI | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5503 | IMNSFVNDIFERI | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5901 | LKQVHPDTGISSKAMGI | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5904 | LKQVHPDTGISSKAMGIMNSFVNDIFERI | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6184 | MGIMNSFVNDIFERI | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6208 | MNSFVNDIFERI | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6211 | MNSFVNDIFERIA | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6220 | MNSFVNDIFERIASEA | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6221 | MNSFVNDIFERIASEAS | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6222 | MNSFVNDIFERIASEASRLA | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6333 | NSFVNDIFERI | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6334 | NSFVNDIFERIAGEASRLA | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6682 | RLLLPGELAKH | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6684 | RLLLPGELAKHAV | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6687 | RLLLPGELAKHAVSEGTK | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6690 | RLLLPGELAKHAVSEGTKAV | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6693 | RLLLPGELAKHAVSEGTKAVT | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6695 | RLLLPGELAKHAVSEGTKAVTKY | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6698 | RLLLPGELAKHAVSEGTKAVTKYTS | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6701 | RLLLPGELAKHAVSEGTKAVTKYTSSK | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6828 | SFVNDIFERI | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7098 | SSKAMGIMNSFVNDIFERI | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7206 | SVYVYKVLKQVHPDTGISSKAMGI | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7964 | VNDIFERI | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7983 | VRLLLPGELAKHAV | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7986 | VRLLLPGELAKHAVSEGTKAV | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7989 | VRLLLPGELAKHAVSEGTKAVTKY | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8106 | VYKVLKQVHPDTGISSKAMGI | Histone H2B type 1-L | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |